BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20857187)

  • 1. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.
    Meade CS; Conn NA; Skalski LM; Safren SA
    J Behav Med; 2011 Apr; 34(2):128-38. PubMed ID: 20857187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.
    Anderson AM; Higgins MK; Ownby RL; Waldrop-Valverde D
    AIDS Care; 2015; 27(3):333-7. PubMed ID: 25484035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.
    Meade CS; Towe SL; Skalski LM; Robertson KR
    Drug Alcohol Depend; 2015 Apr; 149():128-35. PubMed ID: 25697913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging, neurocognition, and medication adherence in HIV infection.
    Ettenhofer ML; Hinkin CH; Castellon SA; Durvasula R; Ullman J; Lam M; Myers H; Wright MJ; Foley J
    Am J Geriatr Psychiatry; 2009 Apr; 17(4):281-90. PubMed ID: 19307857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
    Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
    AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
    Anand P; Springer SA; Copenhaver MM; Altice FL
    AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in cognitive function and medication adherence in HIV-infected adults.
    Becker BW; Thames AD; Woo E; Castellon SA; Hinkin CH
    AIDS Behav; 2011 Nov; 15(8):1888-94. PubMed ID: 21437726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine Use May Moderate the Associations of HIV and Female Sex with Neurocognitive Impairment in a Predominantly African American Population Disproportionately Impacted by HIV and Substance Use.
    Lai H; Celentano DD; Treisman G; Khalsa J; Gerstenblith G; Page B; Mandler RN; Yang Y; Salmeron B; Bhatia S; Chen S; Lai S; Goodkin K; Charurat M
    AIDS Patient Care STDS; 2023 May; 37(5):243-252. PubMed ID: 37083446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users.
    Ingersoll KS; Farrell-Carnahan L; Cohen-Filipic J; Heckman CJ; Ceperich SD; Hettema J; Marzani-Nissen G
    Drug Alcohol Depend; 2011 Jul; 116(1-3):177-87. PubMed ID: 21306837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
    Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
    PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive intra-individual variability within HIV+ adults with and without current substance use.
    Arce RenterĂ­a M; Byrd D; Coulehan K; Miranda C; Fuentes A; Rosario AK; Morris EP; Rivera Mindt M
    Neuropsychology; 2020 Mar; 34(3):321-330. PubMed ID: 31886690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.
    Waldrop-Valverde D; Jones DL; Weiss S; Kumar M; Metsch L
    AIDS Care; 2008 Nov; 20(10):1202-10. PubMed ID: 19012081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Roles of Nonsomatic Depressive Symptomatology, Neurocognitive Function, and Current Substance Use in Medication Adherence in Adults Living With HIV Infection.
    Scott TM; Byrd D; Arce RenterĂ­a M; Coulehan K; Miranda C; Fuentes A; Rivera Mindt M
    J Assoc Nurses AIDS Care; 2018; 29(2):178-189. PubMed ID: 28988793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-taking self-efficacy and medication adherence among HIV-infected cocaine users.
    Waldrop-Valverde D; Dong C; Ownby RL
    J Assoc Nurses AIDS Care; 2013; 24(3):198-206. PubMed ID: 23122904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Substance Use Interferes with Maintenance of HIV Medication Adherence Skills.
    Dale SK; Traeger L; O'Cleirigh C; Bedoya CA; Pinkston M; Wilner JG; Stein M; Safren SA
    AIDS Patient Care STDS; 2016 May; 30(5):215-20. PubMed ID: 27158849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive aspects of medication adherence in HIV infection.
    Selnes OA
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S132-5. PubMed ID: 12562036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.
    Patton DE; Woods SP; Franklin D; Cattie JE; Heaton RK; Collier AC; Marra C; Clifford D; Gelman B; McArthur J; Morgello S; Simpson D; McCutchan JA; Grant I
    AIDS Behav; 2012 Nov; 16(8):2286-96. PubMed ID: 22722882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
    Asiedu N; Kretchy I; Asampong E
    Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.